Abstract
Abstract Arotinolol and its main metabolite, AC 623, both antihypertensive agents with β blocking properties could be separated simultaneously into their two enantiomers and determined in plasma and urine using a solid phase extraction in presence of an internal standard and HPLC using a chiral counterion (Z-glycyl-L-proline) followed by fluorimetric detection. Extraction yields are satisfactory and reproducible. Calibration curves in plasma showed good linearity at levels from 75 to 3 75 ng/ml Arotinolol (97 % R (−) and 3 % S (+) and from 5 to 25 ng/ml AC 623 (80 % R (−) and 20% = S(+)). Absolute amounts of each enantiomer could be calculated from the plasma standard curves, whereas percentages of each enantiomer were estimated from spiked plasma and urine. Both enantiomers of Arotinolol or AC 623 gave similar analytical response. They could be related to total amounts of drugs dosed using non-chiral HPLC (10). Accuracy was estimated from plasma calibration curves (R. E. < 10 % for Arotinolol enantiomers...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.